Security key
98420X103
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR)
CUSIP: 98420X103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 100,589,647
- Total 13F value
- $67,319,848
- Share change
- -1,487,619
- Put/Call ratio
- 24%
- SEC-reported price per share
- $0.67
- Number of holders
- 98
- Value change
- -$551,327
- Number of buys
- 44
- Number of sells
- 28
- Shares outstanding
- 94,372,096
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
98
Top holders
10
XFOR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
X4 Pharmaceuticals, Inc SEC filings
X4 Pharmaceuticals, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420X103
Recent filing periods:
Ownership snapshot
Top reported holders of XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bain Capital Life Science...
Disclosed value leader
Bain Capital Life Science...
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $9,811,155
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $9.81M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.
Disclosed position value
Top 5
Bain Capital Life Sciences Invest...
$9.81M
NEA Management Company, LLC
$8.69M
BlackRock Finance, Inc.
$6.19M
VANGUARD GROUP INC
$4.81M
ORBIMED ADVISORS LLC
$4.14M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
—
denominator unverified
|
$9,811,155
16,915,784 shares
|
— | 30 Jun 2024 |
| NEA Management Company, LLC |
13F
Company
|
—
denominator unverified
|
$8,692,340
14,986,793 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$6,192,059
10,675,963 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$4,808,230
8,290,050 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$4,137,439
7,133,515 shares
|
— | 30 Jun 2024 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
—
denominator unverified
|
$2,681,736
4,623,683 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
98
Shares
100,589,647
Rows available
98
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q1 2026 Across Filers
Q1 2026 holders
2
Q3 2024 holders
98
Holder diff
96
| Investor | Q1 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend